Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Rifapentine/Isoniazid for TB Prevention in Silicosis
NCT02430259Phase 3Completed
- Sponsor
- Huashan Hospital
- Start
- Mar 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifapentine, isoniazid in Tuberculosis (TB), sponsored by Huashan Hospital. Started Mar 2015; status: completed.
02
Drugs
rifapentineisoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02430259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02430259.